Evidence map›Paper›PMID 29313109›Full record

ArticleJournal of gastroenterology2018

Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease.

Junji Umeno, Motohiro Esaki, Atsushi Hirano, Yuta Fuyuno, Naoki Ohmiya, Shigeyoshi Yasukawa, Fumihito Hirai, Shuji Kochi, Koichi Kurahara, Shunichi Yanai and 17 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Molecular basis of prostaglandin ENature communications · 2025
    Article
  9. MUSings on a Crohn's Disease Diagnosis.Digestive diseases and sciences · 2025
    Article
  10. Review
  11. Endocrine Alterations in Patients With Pachydermoperiostosis.The Journal of clinical endocrinology and metabolism · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Cryptogenic multifocal ulcerous stenosing enteritis: A ray of light on the umbra of the dark continent.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Pathogenesis of chronic enteropathy associated with theWorld journal of gastroenterology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 14 institutions in 1 country.

Junji UmenoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Motohiro EsakiDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Atsushi HiranoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yuta FuyunoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Naoki OhmiyaDepartment of Gastroenterology, Fujita Health University School of Medicine, Toyoake, Japan.
Shigeyoshi YasukawaDepartment of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.
Fumihito HiraiDepartment of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.
Shuji KochiDepartment of Gastroenterology, Matsuyama Red Cross Hospital, Matsuyama, Japan.
Koichi KuraharaDepartment of Gastroenterology, Matsuyama Red Cross Hospital, Matsuyama, Japan.
Shunichi YanaiDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.
Keiichi UchidaDepartment of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Tsu, Japan.
Shuhei HosomiDepartment of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kenji WatanabeDepartment of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Naoki HosoeCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
Haruhiko OgataCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
Tadakazu HisamatsuThe Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan.
Manabu NagayamaDivision of Gastroenterology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Hironori YamamotoDivision of Gastroenterology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Daiki AbukawaDepartment of General Pediatrics, Miyagi Children's Hospital, Sendai, Japan.
Fumihiko KakutaDepartment of General Pediatrics, Miyagi Children's Hospital, Sendai, Japan.
Kei OnoderaDepartment of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Toshiyuki MatsuiDepartment of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.
Toshifumi HibiCenter for Advanced IBD Research and Treatment, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan.
Tsuneyoshi YaoSada Hospital, Fukuoka, Japan.
Takanari KitazonoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takayuki MatsumotoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. tmatsumo@iwate-med.ac.jp.
CEAS study group
Kyushu University · JPFukuoka University · JPJichi Medical University · JPMie University · JPSapporo Medical University · JPFujita Health University · JPHyogo Medical University · JPIwate Medical University · JPKeio University · JPKitasato Institute Hospital · JPKyorin University · JPMatsuyama Red Cross Hospital · JPMiyagi Children's Hospital · JPOsaka City University · JP

Funding

Japan Agency for Medical Research and Development 15ek0109053h0002Japan Society for the Promotion of Science 25460953
6 · The paper itself

Abstract

backgroundChronic enteropathy associated with SLCO2A1 gene (CEAS) is a hereditary disease caused by mutations in the SLCO2A1 gene and characterized by multiple small intestinal ulcers of nonspecific histology. SLCO2A1 is also a causal gene of primary hypertrophic osteoarthropathy (PHO). However, little is known about the clinical features of CEAS or PHO.

methodsSixty-five Japanese patients recruited by a nationwide survey of CEAS during 2012-2016 were enrolled in this present study. We reviewed the clinical information of the genetically confirmed CEAS patients.

resultsWe identified recessive SLCO2A1 mutations at 11 sites in 46 patients. Among the 46 patients genetically confirmed as CEAS, 13 were men and 33 were women. The median age at disease onset was 16.5 years, and parental consanguinity was present in 13 patients (28%). Anemia was present in 45 patients (98%), while a single patient experienced gross hematochezia. All patients showed relatively low inflammatory markers in blood tests (median CRP 0.20 mg/dl). The most frequently involved gastrointestinal site was the ileum (98%), although no patient had mucosal injuries in the terminal ileum. Mild digital clubbing or periostosis was found in 13 patients (28%), with five male patients fulfilling the major diagnostic criteria of PHO.

conclusionsThe clinical features of CEAS are distinct from those of Crohn's disease. Genetic analysis of the SLCO2A1 gene is therefore recommended in patients clinically suspected of having CEAS.

Indexed as

AdolescentAdultAgedAge of OnsetAnemiaChildChild, PreschoolChronic DiseaseConsanguinityC-Reactive ProteinCrohn DiseaseDiagnosis, DifferentialFemaleGenetic TestingHumansInfantC-Reactive ProteinOrganic Anion TransportersSLCO2A1 protein, humanChronic nonspecific multiple ulcers of the small intestineCrohn’s diseasePachydermoperiostosisPrimary hypertrophic osteoarthropathyProstaglandin transporter

Identifiers

PMID29313109
PMCPMC6061663
OpenAlexW2782948201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.